ImportantUpdates
Bajaj Healthcare reports Q3 revenue of ₹161.22 Cr, PAT ₹15.67 Cr.
Bajaj Healthcare LimitedBAJAJHCARE · Filed with the exchange
Nine-month revenue hit ₹457.97 Cr, PAT ₹38.62 Cr.
Board approved re-appointing key directors for three-year terms.
Acquisition of Genrx Pharma for ₹10.85 Cr is pending NCLT approval.
No comments yet. Be the first.